scholarly article | Q13442814 |
P356 | DOI | 10.1006/JMBI.2000.4026 |
P698 | PubMed publication ID | 10966812 |
P2093 | author name string | Marks JD | |
Nielsen UB | |||
Becerril B | |||
Poul MA | |||
Morisson P | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 1149-1161 | |
P577 | publication date | 2000-09-01 | |
P1433 | published in | Journal of Molecular Biology | Q925779 |
P1476 | title | Selection of tumor-specific internalizing human antibodies from phage libraries | |
P478 | volume | 301 |
Q92134767 | ---Successful Application of Whole Cell Panning for Isolation of Phage Antibody Fragments Specific to Differentiated Gastric Cancer Cells |
Q38869540 | A Cell-Based Internalization and Degradation Assay with an Activatable Fluorescence-Quencher Probe as a Tool for Functional Antibody Screening |
Q98625902 | A Functional Screening Strategy for Engineering Chimeric Antigen Receptors with Reduced On-Target, Off-Tumor Activation |
Q33185074 | A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. |
Q77958509 | A new RNase-based immunoconjugate selectively cytotoxic for ErbB2-overexpressing cells |
Q33259109 | A novel assay for monitoring internalization of nanocarrier coupled antibodies |
Q36332226 | A novel excision selection method for isolation of antibodies binding antigens expressed specifically by rare cells in tissue sections |
Q34212777 | A novel in vivo method for isolating antibodies from a phage display library by neuronal retrograde transport selectively yields antibodies against p75(NTR.). |
Q64247359 | A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions |
Q24813872 | A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda |
Q33388079 | A yeast display immunoprecipitation method for efficient isolation and characterization of antigens |
Q34979754 | An improved single-chain Fab platform for efficient display and recombinant expression |
Q91808144 | Antibody Structure and Function: The Basis for Engineering Therapeutics |
Q34460171 | Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources |
Q33841864 | Beyond natural antibodies: the power of in vitro display technologies |
Q28484366 | Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide |
Q37279686 | Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine |
Q26992196 | Chemical strategies for the covalent modification of filamentous phage |
Q31123016 | Colony lift assay using cell-coated filters: a fast and efficient method to screen phage libraries for cell-binding clones |
Q31119779 | Combinatorial approaches for the identification of brain drug delivery targets |
Q35659188 | Combining Phage and Yeast Cell Surface Antibody Display to Identify Novel Cell Type-Selective Internalizing Human Monoclonal Antibodies |
Q31077432 | Construction and exploitation in model experiments of functional selection of a landscape library expressed from a phagemid |
Q33222167 | Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library |
Q92372816 | Coupling Brain Perfusion Screens and Next Generation Sequencing to Identify Blood-Brain Barrier Binding Antibodies |
Q40077818 | Current progress in innovative engineered antibodies |
Q40603151 | De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods |
Q33283622 | Design of synthetic antibody libraries |
Q34630307 | Designing immunotoxins for cancer therapy. |
Q33362888 | Development of human single-chain antibodies against SARS-associated coronavirus |
Q47209586 | Discovery of internalizing antibodies to basal breast cancer cells |
Q34114794 | Discovery of internalizing antibodies to tumor antigens from phage libraries |
Q45884338 | Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv |
Q28201899 | Engineered antibodies |
Q28551823 | Engineering an Anti-Transferrin Receptor ScFv for pH-Sensitive Binding Leads to Increased Intracellular Accumulation |
Q33763294 | Fusogenics: a recombinant immunotoxin-based screening platform to select internalizing tumor-specific antibody fragments |
Q33480823 | Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo |
Q34421055 | High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display |
Q30605298 | High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies |
Q37394278 | Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies |
Q33409529 | Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion |
Q33284494 | Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies |
Q24646373 | Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma |
Q33257951 | Identification of clinically significant tumor antigens by selecting phage antibody library on tumor cells in situ using laser capture microdissection |
Q34459039 | Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens |
Q33620053 | Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells |
Q31114638 | Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines |
Q33816474 | Identifying blood-brain-barrier selective single-chain antibody fragments |
Q33289414 | Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells |
Q50476547 | Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting. |
Q28208361 | Improving the efficacy of antibody-based cancer therapies |
Q33258073 | In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice |
Q33260542 | Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer. |
Q43975038 | Interactions between anti-ErbB2 antibody A21 and the ErbB2 extracellular domain provide a basis for improving A21 affinity |
Q33695432 | Internalizing Cancer Antibodies from Phage Libraries Selected on Tumor Cells and Yeast-Displayed Tumor Antigens |
Q30890428 | Internalizing antibodies and targeted cancer therapy: direct selection from phage display libraries |
Q34757809 | Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies |
Q33675610 | Isolation of a human anti-epidermal growth factor receptor Fab antibody, EG-19-11, with subnanomolar affinity from naïve immunoglobulin repertoires using a hierarchical antibody library system |
Q33350679 | Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML). |
Q21256651 | Killing cancer cells by targeted drug-carrying phage nanomedicines |
Q36540601 | Ligand-targeted delivery of therapeutic siRNA. |
Q35157616 | Ligand-targeted liposomal anticancer drugs |
Q35895637 | Ligand-targeted theranostic nanomedicines against cancer |
Q33268344 | Mining a yeast library for brain endothelial cell-binding antibodies |
Q30695353 | Molecular addresses in blood vessels as targets for therapy. |
Q27643327 | Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin |
Q36023978 | Phage display library selection of a hypoxia-binding scFv antibody for liver cancer metabolic marker discovery |
Q33214333 | Phage display selection for cell-specific ligands: development of a screening procedure suitable for small tumor specimens |
Q30712277 | Phage versus phagemid libraries for generation of human monoclonal antibodies. |
Q36452621 | Potent antibody therapeutics by design |
Q40421390 | Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification |
Q33205947 | Production of a human single-chain variable fragment antibody against esophageal carcinoma |
Q33237134 | Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae |
Q35234519 | Profiling receptor tyrosine kinase activation by using Ab microarrays |
Q31016849 | Protein-protein interactions in hematology and phage display |
Q30996928 | Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy. |
Q33287000 | Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer |
Q33246250 | Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer |
Q34280931 | Selection and characterization of cell binding and internalizing phage antibodies |
Q30982238 | Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library |
Q90241493 | Strategies for Selecting Membrane Protein-Specific Antibodies using Phage Display with Cell-Based Panning |
Q34616688 | Streamlining hit discovery and optimization with a yoctoliter scale DNA reactor |
Q33193572 | Synthetic Compound Libraries Displayed on the Surface of Encoded Bacteriophage |
Q90611396 | Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma-associated antigens via human scFv antibodies |
Q33322420 | Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies |
Q33263078 | The use of immunoliposome for nutrient target regulation (a review). |
Q31122757 | The use of phage display in the study of receptors and their ligands |
Q31104590 | Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis |
Q31087157 | Tumor cell-targeting by phage-displayed peptides. |
Q35659193 | Yeast Display-Based Antibody Affinity Maturation Using Detergent-Solubilized Cell Lysates |
Search more.